← American Veterinary Medical Association
FDARulemakingFDA-2023-N-5160

Labeling Requirements for Approved or Conditionally Approved New Animal Drugs

RIN
—
Last modified
Aug 26, 2024
Comment window
closed 718d ago
American Veterinary Medical Association filings
1

Activity

American Veterinary Medical Association filed 1 comment on this docket between Aug 12, 2024 and Aug 12, 2024. 1 other organizations filed here. The comment window closed 718d ago.

What American Veterinary Medical Association filed (1)

Aug 12, 2024· Comment from American Veterinary Medical Association (AVMA)· FDA-2023-N-5160-0030

Filed on regulations.gov — full text not in the inline record.

View on regulations.gov →

Abstract

The Food and Drug Administration (FDA) is proposing to revise the requirements for the content and format of labeling for approved or conditionally approved new animal drugs to provide for a more comprehensive set of requirements in one location in the Code of the Federal Register (CFR). As part of this revision, certain current requirements would be updated and moved, and certain obsolete requirements would be removed. The proposed requirements would apply to the labeling of prescription and over-the-counter (OTC) new animal drugs, as well as new animal drugs for use in animal feeds.

View on regulations.gov →

Co-filers (1)

See everyone who commented →